{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:06:42Z","timestamp":1784567202155,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.imlet.2026.107201","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:24:00Z","timestamp":1780759440000},"page":"107201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Could bradykinin pathway inhibition change the course of severe hantavirus disease?"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9970-2720","authenticated-orcid":false,"given":"Marina","family":"Weerheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2026.107201_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-096313","article-title":"Prognostic factors for mortality in patients infected with New World hantaviruses: a systematic review and meta-analysis","volume":"16","author":"Tortosa","year":"2026","journal-title":"BMJ Open."},{"key":"10.1016\/j.imlet.2026.107201_bib0002","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13937","article-title":"Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology","volume":"144","author":"Manigold","year":"2014","journal-title":"Swiss Med. Wkly."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2026.107201_bib0003","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virusres.2011.09.017","article-title":"Hantavirus pulmonary syndrome","volume":"162","author":"Macneil","year":"2011","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.imlet.2026.107201_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/rmv.1722","article-title":"Hantavirus infections in Europe and their impact on public health","volume":"23","author":"Vaheri","year":"2013","journal-title":"Rev. Med. Virol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107201_bib0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jaci.2020.08.038","article-title":"Pulmonary edema in COVID-19: explained by bradykinin?","volume":"146","author":"Zwaveling","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2026.107201_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104195","article-title":"Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19","volume":"83","author":"Martens","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.imlet.2026.107201_bib0007","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/cid\/ciac984","article-title":"Three-day icatibant on top of standard care in patients with coronavirus disease 2019 pneumonia: a randomized, open-label, phase 2, proof-of-concept trial","volume":"76","author":"Malchair","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2026.107201_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003470","article-title":"Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system","volume":"9","author":"Taylor","year":"2013","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.imlet.2026.107201_bib0009","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3109\/00365548.2012.755268","article-title":"A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant","volume":"45","author":"Antonen","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2026.107201_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00365548.2014.969304","article-title":"Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant","volume":"47","author":"Laine","year":"2015","journal-title":"Infect. Dis. (Lond)"},{"key":"10.1016\/j.imlet.2026.107201_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.08.007","article-title":"Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant","volume":"111","author":"Vaheri","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.imlet.2026.107201_bib0012","article-title":"Immunopathogenesis of different emerging viral infections: evasion, fatal mechanism, and prevention","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782600074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782600074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:43:22Z","timestamp":1784565802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524782600074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"alternative-id":["S016524782600074X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107201","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could bradykinin pathway inhibition change the course of severe hantavirus disease?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107201"}}